Copyright
©The Author(s) 2016.
World J Gastrointest Surg. Jan 27, 2016; 8(1): 5-26
Published online Jan 27, 2016. doi: 10.4240/wjgs.v8.i1.5
Published online Jan 27, 2016. doi: 10.4240/wjgs.v8.i1.5
Ref. | No. of studies/period | Type of studies | End point | No. of OLR × LLR | Conversion rate | Favors ORL | Favors LLR | Equal OLR × LLR |
Simillis et al[151] | 8 | Observational | Short-term outcomes | 244 (59.7%) × 165 (40.3%) | 3.7% | Need and duration of portal clamping | Operative blood loss | Blood transfusion rate |
Nonrandomized | Return to oral intake | Operative time | ||||||
Comparative | LOS | Incidence of portal triad clamping | ||||||
1998-2005 | Benign and malignant disease | Adverse events | ||||||
Oncologic clearance | ||||||||
Croome et al[150] | 26 | Observational | Short and long-term outcomes | 1019 (53.9%) × 871 (46.1%) | 3.5% | Lower risk of margins smaller than 1 cm | Operative blood loss | Blood transfusion rate |
Nonrandomized | Return to oral intake | Operative time | ||||||
Comparative | Need for intravenous narcotics | Incidence of portal triad clamping | ||||||
1998-2009 | Benign and malignant disease | Overall complication rate | Oncologic clearance | |||||
All cause mortality in 2-5 yr | Recurrence risk | |||||||
Mirnezami et al[149] | 26 | Observational | Short and long-term outcomes | 961 (57%) × 717 (43%) | 7% | Operative time | Operative blood loss | Portal trial clamping time |
Nonrandomized | Return to oral intake | Margin size | ||||||
Comparative | Overall and specific complications | Hepatic tumor recurrence for HCC | ||||||
1998-2009 | Benign and malignant disease | Incidence of portal triad clamping | DFS for HCC | |||||
Lower risk of margins smaller than 1 cm | ||||||||
Lower rate of positive margins | ||||||||
Increased overall survival for HCC | ||||||||
Zhou et al[118] | 10 | Observational | Short and long-term outcomes | 281 (56.9%) × 213 (43.1%) | 6.1% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Postoperative mortality | ||||||
Comparative | Overall and liver specific complications | Size of resection margins | ||||||
2001-2010 | HCC only | LOS | DFS | |||||
Overall survival | ||||||||
Mizuguchi et al[152] | 11 | Observational | Short-term outcomes | 253 (52.2%) × 232 (47.8%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Postoperative complications | |||||||
Comparative | LOS | |||||||
2001-2008 | Benign and malignant disease | |||||||
Fancellu et al[111] | 9 | Observational | Short and long-term outcomes | 363 (61.5%) × 227 (38.5%) | 4% | - | Rate of positive margins | Liver haemorrhage |
Nonrandomized | Operative blood loss | Bile leakage | ||||||
Comparative | Blood transfusion rate | OS | ||||||
2001-2010 | HCC only | LOS | DFS | |||||
Overall and liver specific complications | ||||||||
Rao et al[94] | 7 | Observational | Short-term outcomes | 111 (45.3%) × 134 (54.7%) | 2.7% | - | Postoperative complications | Operative blood loss |
Nonrandomized | Operative time | Blood transfusion rate | ||||||
2005-2009 | Comparative only patients undergoing laparoscopic × open LLS | LOS | Rate of positive margins | |||||
Li et al[173] | 10 | Observational | Short and long-term outcomes | 383 (61%) × 244 (39%) | 6.6% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Surgical margin size | ||||||
Comparative | Postoperative complications | Rate of positive margins | ||||||
2001-2011 | HCC only | LOS | Tumor recurrence | |||||
Rao et al[148] | 32 | Observational | Short and long-term outcomes | 1305 (52.9%) x 1161 (47.1%) | 2.3% | Operative time | Operative blood loss | Overall and liver specific complications |
Nonrandomized | Blood transfusion rate | Operative mortality | ||||||
Comparative | LOS | Margin width | ||||||
1998-2009 | Benign and malignant disease | Return to oral intake | DFS | |||||
Rate of positive margins | OS | |||||||
Overall complication rate | Recurrence rate | |||||||
Xiong et al[117] | 15 | Observational | Short and long-term outcomes | 316 (57.5%) × 234 (42.5%) | 0% to 19.4% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Pulmonary complications | ||||||
Comparative | LOS | Bleeding | ||||||
2001-2011 | HCC only | Incidence of liver failure and ascites | Bile leakage | |||||
Operative mortality | ||||||||
Rate of positive margins | ||||||||
Tumor recurrence | ||||||||
Rao et al[172] | 10 | Observational | Short-term outcomes | 404 (57.7%) × 296 (42.3%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Ascitis | ||||||
2002-2009 | Comparative | Negative margins rate | Postoperative liver failure | |||||
Malignant tumors | Overall complication rate | DFS | ||||||
LOS | OS | |||||||
Recurrence rate | ||||||||
Yin et al[174] | 15 | Observational | Short and long-term outcomes | 753 (60.8%) × 485 (39.2%) | 2.6% | - | Operative blood loss | Surgical margins |
Nonrandomized | Blood transfusion rate | Operative time | ||||||
Comparative | Postoperative morbidity | Negative margins rate | ||||||
2001-2011 | HCC only | LOS | Recurrence rate | |||||
OS | ||||||||
RFS | ||||||||
Zhou et al[129] | 8 | Observational | Short and long-term outcomes | 427 (61.4%) × 268 (38.6%) | 8.2% | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | |||||||
Comparative | Postoperative morbidity | |||||||
2002-2013 | CRLM only | LOS | ||||||
Negative margin | ||||||||
OS | ||||||||
DFS | ||||||||
Twaij et al[168] | 4 | Observational | Short and long-term outcomes | 270 (64.3%) × 150 (35.7%) | 7% to 19.4% | - | Surgical margin size | Operative time |
Nonrandomized | Operative blood loss | OS | ||||||
Comparative | Blood transfusion rate | DFS | ||||||
2009-2013 | HCC only with cirrhosis | Postoperative morbidity | ||||||
Parks et al[167] | 15 | Observational | Short and long-term outcomes | 556 (55.5%) × 446 (44.5%) | 4.2% | - | Operative blood loss | Operative time |
Nonrandomized | LOS | 30-d mortality | ||||||
Comparative | OS | |||||||
2001-2011 | Malignant tumors | |||||||
Luo et al[128] | 7 | Observational | Short and long-term outcomes | 383 (61.4%) × 241 (38.6%) | NR | Margin size | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | LOS | ||||||
Comparative | Postoperative complications | OS | ||||||
2002-2013 | CRLM only | Rate of R1 margins | DFS | |||||
Wei et al[127] | 14 | Observational | Short and long-term outcomes | 599 (61.4%) × 376 (38.6%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Perioperative mortality | ||||||
2002-2013 | Comparative | LOS | OS | |||||
CRLM only | Postoperative complications | DFS | ||||||
13 studies comparing simultaneous | ||||||||
laparoscopic × open resections | 1Simultaneous resection | 1Simultaneous resection | ||||||
LOS | Morbidity, operative time, operative blood loss | |||||||
Schiffman et al[130] | 8 | Observational | Short and long-term outcomes | 368 (60.3%) × 242 (39.7%) | NR | - | Operative blood loss | Operative time |
Nonrandomized | Blood transfusion rate | Number of major resections | ||||||
Comparative | Overall complication rate | Mean number of resected tumors | ||||||
2009-2013 | CRLM only | LOS | Tumor size | |||||
Positive margins | ||||||||
Margin width | ||||||||
OS | ||||||||
DFS | ||||||||
Jackson et al[153] | 46 | Observational | Short-term outcomes | 1741 (47.8%) × 1901 (52.2%) | 5.68% | Cost | Operative blood loss | Operative time |
Nonrandomized | Negative margin | 30-d mortality | ||||||
2001-2013 | Comparative | LOS | ||||||
Benign and malignant disease | Postoperative complications | |||||||
Morise et al[169] | 21 | Observational | Ascitis | 602 (63.1%) | NR | - | Less ascites | - |
Nonrandomized | × 352 (36.9%) | Less postoperative liver failure | ||||||
2001-2014 | Comparative | |||||||
HCC only | Postoperative liver failure | 220 (54.6%) × 183 (45.7%) |
- Citation: Coelho FF, Kruger JAP, Fonseca GM, Araújo RLC, Jeismann VB, Perini MV, Lupinacci RM, Cecconello I, Herman P. Laparoscopic liver resection: Experience based guidelines. World J Gastrointest Surg 2016; 8(1): 5-26
- URL: https://www.wjgnet.com/1948-9366/full/v8/i1/5.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v8.i1.5